The anti-inflammatory cytokine transforming growth factor-β (TGF-β) also promotes tumor progression in PDAC by inhibiting of immune activation, and deletion of the TGF-β receptor in CD8+ T cells enhanced infiltration and cytotoxicity of TILs in mouse models [21]. The gene discussed is CD8A; the disease is neoplasm.